Zipant 40 Tablet contains Pantoprazole 40 mg, a proton pump inhibitor (PPI) used to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and other conditions associated with excessive stomach acid production. Pantoprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step of acid production. This results in decreased gastric acidity, promoting healing of acid-related damage and alleviating symptoms such as heartburn and acid regurgitation. Zipant 40 is typically administered orally once daily, preferably before a meal, with dosage and duration tailored to the specific condition and patient response. It is generally well tolerated; common adverse effects may include headache, diarrhea, nausea, abdominal pain, and dizziness. Caution is advised in patients with liver impairment, and long-term use should be monitored due to potential risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Zipant 40 should be used under medical supervision, with consideration of drug interactions and contraindications to ensure safe and effective therapy.